METHOD OF DETERMINING DOSE OF ERYTHROPOIESIS-STIMULATING AGENT

A method of determining an ESA dose, which allows a hemoglobin concentration in the blood to be stably maintained at a target value, and which can decrease a range of fluctuation of the hemoglobin concentration with respect to the target value. The method comprises the steps of: setting the target v...

Full description

Saved in:
Bibliographic Details
Main Authors SHINZATO TORU, MARUYAMA YASUYO, UENO FUMIHIKO
Format Patent
LanguageEnglish
Published 24.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method of determining an ESA dose, which allows a hemoglobin concentration in the blood to be stably maintained at a target value, and which can decrease a range of fluctuation of the hemoglobin concentration with respect to the target value. The method comprises the steps of: setting the target value of the hemoglobin concentration in the blood; calculating a target value of a hemoglobin production rate which allows the hemoglobin concentration to reach the target value; calculating a serum ESA concentration which allows the hemoglobin production rate to reach the target value, from a relationship between the hemoglobin production rate and the ESA concentration; and calculating an amount of administration of an ESA which gives the serum ESA concentration, from a relationship between the ESA concentration and the amount of administration of the ESA, to determine an ESA dose which allows the hemoglobin concentration to reach the target value.
Bibliography:Application Number: US201514960801